Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saraswati Sukumar

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancerVered Stearns, Lisa K Jacobs, Maryjo Fackler, et al.
Clinical Epigenetics|April 20, 2024
Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countriesMary Jo Fackler, Madison Pleas, Youran Li, et al.
Nature|April 16, 2010
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasisRajnish A Gupta, Nilay Shah, Kevin C Wang, et al.
Science Advances|April 2, 2020
Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancerPreethi Korangath, James D Barnett, Anirudh Sharma, et al.
Cancer Research|January 21, 2016
Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast CancerVanessa F Merino, Nguyen Nguyen, Kideok Jin, et al.
Angewandte Chemie (International Ed. in English)|October 9, 2019
Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D MicroarraysZufeng Guo, Zhiqiang Cheng, Jingxin Wang, et al.
Cancer Research|April 17, 2014
Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancerMary Jo Fackler, Zoila Lopez Bujanda, Christopher Umbricht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2022
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective TrialKala Visvanathan, Leslie Cope, Mary Jo Fackler, et al.
Oncogene|August 3, 2021
CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancerYu Yan, Athira Narayan, Soonweng Cho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker StudyKala Visvanathan, MaryJo S Fackler, Zhe Zhang, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2013
Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancerVered Stearns, Lisa K Jacobs, Maryjo Fackler, et al.
Clinical Epigenetics|April 20, 2024
Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countriesMary Jo Fackler, Madison Pleas, Youran Li, et al.
Nature|April 16, 2010
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasisRajnish A Gupta, Nilay Shah, Kevin C Wang, et al.
Science Advances|April 2, 2020
Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancerPreethi Korangath, James D Barnett, Anirudh Sharma, et al.
Cancer Research|January 21, 2016
Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast CancerVanessa F Merino, Nguyen Nguyen, Kideok Jin, et al.
Angewandte Chemie (International Ed. in English)|October 9, 2019
Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D MicroarraysZufeng Guo, Zhiqiang Cheng, Jingxin Wang, et al.
Cancer Research|April 17, 2014
Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancerMary Jo Fackler, Zoila Lopez Bujanda, Christopher Umbricht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2022
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective TrialKala Visvanathan, Leslie Cope, Mary Jo Fackler, et al.
Oncogene|August 3, 2021
CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancerYu Yan, Athira Narayan, Soonweng Cho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker StudyKala Visvanathan, MaryJo S Fackler, Zhe Zhang, et al.
Pageof 17